Search Results - "Nagano, Luis F."

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas by de Sousa, Graziella R., Salomão, Karina B., Nagano, Luis F. P., Riemondy, Kent A., Chagas, Pablo S., Veronez, Luciana C., Saggioro, Fabiano P., Marie, Suely K. N., Yunes, José A., Cardinalli, Izilda A., Brandalise, Silvia R., de Paula Queiroz, Rosane G., Scrideli, Carlos A., Donson, Andrew M., Foreman, Nicholas K., Tone, Luiz G., Valera, Elvis T.

“…Members of the HDAC family are predictive biomarkers and regulate the tumorigenesis in several cancers. However, the role of these genes in the biology of…”
Get full text

MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways by Veronez, Luciana C., Chagas, Pablo F., Corrêa, Carolina A. P., Baroni, Mirella, Silva, Keteryne R., Nagano, Luis F., Borges, Kleiton S., Queiroz, Rosane G. P., Tone, Luiz G., Scrideli, Carlos A.

“…Adrenocortical carcinoma (ACC) is a rare, but highly aggressive cancer of the adrenal cortex with a generally poor prognosis. Despite being rare, completely…”
Get full text

Novel anti-prostate cancer scaffold identified by the combination of in silico and cell-based assays targeting the PI3K-AKT-mTOR pathway by Saidel, Marta Érica, dos Santos, Karen C., Nagano, Luís F.P., Montanari, Carlos Alberto, Leitão, Andrei

“…[Display omitted] Phenotypic assays were performed in prostate cancer cell lines to describe the biological activity of PI3K-AKT-mTOR pathway inhibitors…”
Get full text